F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
24.99
-0.40 (-1.58%)
At close: Jul 18, 2025, 4:00 PM
24.99
0.00 (0.00%)
After-hours: Jul 18, 2025, 4:15 PM EDT
LFSC Holdings Information
LFSC is an equity ETF with a total of 35 individual holdings. The top holdings are BridgeBio Pharma stock at 6.77%, Soleno Therapeutics at 6.00%, RadNet at 5.95%, LivaNova at 5.69%, and Travere Therapeutics at 5.55%.
Total Holdings
35
Top 10 Percentage
53.47%
Asset Class
Equity
ETF Category
Health
Assets
59.15M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | BBIO | BridgeBio Pharma, Inc. | 6.77% |
| 2 | SLNO | Soleno Therapeutics, Inc. | 6.00% |
| 3 | RDNT | RadNet, Inc. | 5.95% |
| 4 | LIVN | LivaNova PLC | 5.69% |
| 5 | TVTX | Travere Therapeutics, Inc. | 5.55% |
| 6 | TMDX | TransMedics Group, Inc. | 5.43% |
| 7 | KALV | KalVista Pharmaceuticals, Inc. | 5.11% |
| 8 | COLL | Collegium Pharmaceutical, Inc. | 4.44% |
| 9 | INSM | Insmed Incorporated | 4.37% |
| 10 | MMSI | Merit Medical Systems, Inc. | 4.17% |
| 11 | ETNB | 89bio, Inc. | 4.11% |
| 12 | MDGL | Madrigal Pharmaceuticals, Inc. | 3.71% |
| 13 | WVE | Wave Life Sciences Ltd. | 3.38% |
| 14 | GH | Guardant Health, Inc. | 3.32% |
| 15 | ATEC | Alphatec Holdings, Inc. | 3.28% |
| 16 | RARE | Ultragenyx Pharmaceutical Inc. | 2.86% |
| 17 | CORT | Corcept Therapeutics Incorporated | 2.84% |
| 18 | MIRM | Mirum Pharmaceuticals, Inc. | 2.67% |
| 19 | COGT | Cogent Biosciences, Inc. | 2.53% |
| 20 | ITGR | Integer Holdings Corporation | 2.23% |
| 21 | AXSM | Axsome Therapeutics, Inc. | 2.11% |
| 22 | ACAD | ACADIA Pharmaceuticals Inc. | 1.94% |
| 23 | AKRO | Akero Therapeutics, Inc. | 1.71% |
| 24 | SYRE | Spyre Therapeutics, Inc. | 1.51% |
| 25 | GMED | Globus Medical, Inc. | 1.37% |
As of Jul 16, 2025